Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7396918
IGF-I fusion polypeptides and therapeutic uses thereof
granted -
US 7396664
VEGF-binding fusion proteins and nucleic acids encoding the same
granted -
US 7378095
Methods of treating type I diabetes by blocking VEGF-mediated activity
granted -
US 7374757
Modified chimeric polypeptides with improved pharmacokinetic properties
granted -
US 7374758
Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof
granted -
US 7365165
IL-1 antagonist formulations
granted -
US 7361350
Use of an IL-1 antagonist for treating arthritis
granted -
US 7354580
Method of administering and using VEGF inhibitors for the treatment of human cancer
granted -
US 7354582
Use of VEGF antagonists for the treatment of malignant gliomas
granted -
US 7355018
Modified IGF1 polypeptides with increased stability and potency
granted -
US 7354581
Therapeutic combination of a VEGF antagonist and anti-hypertensive agent
granted -
US 7354579
Method of treating cancer with a VEGF antagonist and an anti-proliferative agent
granted -
US 7354578
Method of tumor regression with VEGF inhibitors
granted -
US 7351411
Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF)
granted -
US 7309483
Method of treatment using Tie2 ligand2
granted -
US 7306799
Use of VEGF inhibitors for treatment of eye disorders
granted -
US 7303746
Methods of treating eye disorders with modified chimeric polypeptides
granted -
US 7303747
Use of VEGF inhibitors for treatment of eye disorders
granted -
US 7303748
Method of treating eye injury with local administration of a VEGF inhibitor
granted -
US 7300653
Method of treating corneal transplant rejection
granted -
US 7300654
Method of treating corneal transplant rejection in high risk keratoplasty patients
granted -
US 7285532
Therapeutic method for treating bone formation diseases
granted -
US 7279159
VEGF inhibitor polypeptides
granted -
US 7241739
Morphogenic protein
granted